Security key
98420N105
Xenon Pharmaceuticals Inc. - Common Shares (XENE)
CUSIP: 98420N105
Q3 2021 13F Holders as of 30 Sep 2021
- Security type / class
- Equity / Common Shares
- Total 13F shares
- 34,071,867
- Total 13F value
- $521,082,671
- Share change
- +457,768
- Put/Call ratio
- 66%
- SEC-reported price per share
- $15.28
- Number of holders
- 113
- Value change
- +$347,889
- Number of buys
- 57
- Number of sells
- 37
- Shares outstanding
- 92,799,600
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2021
Institutions
113
Top holders
10
XENE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2021
Previous quarter: Q2 2021
Xenon Pharmaceuticals Inc. SEC filings
Xenon Pharmaceuticals Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98420N105
Recent filing periods:
Ownership snapshot
Top reported holders of XENE - Xenon Pharmaceuticals Inc. - Common Shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Avoro Capital Advisors LLC
Disclosed value leader
Avoro Capital Advisors LLC
Comparable rows
15/15
Latest evidence
30 Jun 2021
13F
Lead comparable stake: 3.9%
Showing 1-6 of 15 holder rows.
Quick read
Avoro Capital Advisors LLC leads the comparable SEC ownership view at 3.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Avoro Capital Advisors LLC's linked filing trail.
Comparable ownership
Top 5
Avoro Capital Advisors LLC
3.9%
FMR LLC
3.3%
PERCEPTIVE ADVISORS LLC
1.8%
BVF INC/IL
1.7%
ADAGE CAPITAL PARTNERS GP, L.L.C.
1.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Avoro Capital Advisors LLC |
13F
Company
|
3.9%
|
$67,963,000
3,650,000 shares
|
— | 30 Jun 2021 |
| FMR LLC |
13F
Company
|
3.3%
|
$57,209,000
3,072,444 shares
|
— | 30 Jun 2021 |
| PERCEPTIVE ADVISORS LLC |
13F
Company
|
1.8%
|
$31,262,000
1,678,973 shares
|
— | 30 Jun 2021 |
| BVF INC/IL |
13F
Company
|
1.7%
|
$29,267,000
1,571,778 shares
|
— | 30 Jun 2021 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
Company
|
1.6%
|
$28,396,000
1,525,000 shares
|
— | 30 Jun 2021 |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
Company
|
1.6%
|
$27,744,000
1,490,000 shares
|
— | 30 Jun 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
113
Shares
34,071,867
Rows available
113
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2021 vs Q2 2021 Across Filers
Q2 2021 holders
99
Q3 2021 holders
113
Holder diff
14
| Investor | Q2 2021 Shares | Q3 2021 Shares | Share Diff | Share Chg % | Q2 2021 value | Q3 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend